Engineered nanoparticles potentials in male reproduction
Andrology · 2025
DOI: 10.1111/andr.13729 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Andrology, 2025. Verfasst von Feifei Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou…. Hauptthemen laut MEDLINE: Nanoparticles, Testicular Diseases, Reproduction, Infertility, Male. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Fellowship of China Postdoctoral Science Foundation, Medical Technologies R&D Program of He'nan.
Abstract (Originalsprache)
Background
The escalating prevalence of fertility problems in the aging population necessitates a comprehensive exploration of contributing factors, extending beyond environmental concerns, work‐related stress, and unhealthy lifestyles. Among these, the rising incidence of testicular disorders emerges as a pivotal determinant of fertility issues. Current treatment challenges are underscored by the limitations of high‐dose and frequent drug administration, coupled with substantial side effects and irreversible trauma inflicted by surgical interventions on testicular tissue. Material and methods The formidable barrier posed by the blood–testis barrier compounds the complexities of treating testicular diseases, presenting a significant therapeutic obstacle. The advent of nanocarriers, with their distinctive attributes, holds promise in overcoming this impediment. These nanocarriers exhibit exceptional biocompatibility, and membrane penetration capabilities, and can strategically target the blood–testis barrier through surface ligand modification, thereby augmenting drug bioavailability and enhancing therapeutic efficacy. Results and discussion This review concentrates on the transformative potential of nanocarriers in the delivery of therapeutic agents to testicular tissue. By summarizing key applications, we illuminate the strides made in utilizing nanocarriers as a novel avenue to effectively treat testicular diseases.
Conclusions
Nanocarriers are critical in delivering therapeutic agents to testicular tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Henan Key Laboratory of Brain Targeted Bio-nanomedicine, School of Life Sciences, Henan University, Kaifeng, Henan, China.
- Department of Radiotherapy and Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, Henan, China.
- School of Environmental and Life Sciences, College of Engineering, Science and Environmental Science, University of Newcastle, Callaghan, Australia.
ORCID-Profile: Feifei Zhao, Robert John Aitken
Förderung
- National Natural Science Foundation of China
- Fellowship of China Postdoctoral Science Foundation
- Medical Technologies R&D Program of He'nan
- Natural Science Foundation of Henan Province of China
- Henan Province Innovation Research and Development Special Project (Talent Introduction Special Project) - Henan Province High-Level Talent International Train…
Zitieren
APA
Zhao, F., Fan, M., Jing, Z., Zhang, Y., Wang, Y., Zhou, C., Liu, Y., Aitken, R. J., & Xia, X. (2025). Engineered nanoparticles potentials in male reproduction. Andrology. https://doi.org/10.1111/andr.13729
Vancouver
Zhao F, Fan M, Jing Z, Zhang Y, Wang Y, Zhou C, et al. Engineered nanoparticles potentials in male reproduction. Andrology. 2025. doi:10.1111/andr.13729
BibTeX
@article{Zhao2025,
author = {Zhao, Feifei and Fan, Mengyu and Jing, Zhiyang and Zhang, Yanxu and Wang, Yanlin and Zhou, Congli and Liu, Yang and Aitken, Robert John and Xia, Xue},
title = {Engineered nanoparticles potentials in male reproduction},
journal = {Andrology},
year = {2025},
doi = {10.1111/andr.13729}
}
EUVIMED